Laser light could take the ouch out of ankle sprains

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient male or female with age ≥18 years old 2. Patient with diagnosis of LAS (as confirmed by physical examination) to be treated by LightForce® Therapy Lasers according to its indications. 3. Patient suffering from LAS pain for no more than 72 hours prior to enrollment 4. Pain (either persistent or during activities) score reported by the subject at baseline ≥ 40 mm measured on VAS 5. Patient able to provide written informed consent Exclusion Criteria: 1. Patient with musculoskeletal pathological conditions not to be treated with/contraindication to the use of LightForce® Therapy Lasers according to its intended use and indications 2. Patients who are taking drugs that have heat or light sensitive contraindications, such as but not limited to certain types of steroids 3. Patients who have been administered with corticosteroids after injury 4. Pregnant females or females of childbearing potentially planning to become pregnant during the study participation 5. Patients who had systemic inflammatory conditions (i.e. rheumatoid arthritis, polymyalgia rheumatica) 6. Patients affected by chronic ankle instability (recurrent sprains, ankle instability, functional ankle instability, mechanical ankle instability fol¬lowing the first-time injury) 7. Patients with bilateral ankle sprain 8. Patients who have a disease that would limit their participation in exercises (i.e. severe chronic obstructive pulmonary disease, severe heart failure, cerebrovascular event history) 9. Patients with fractures (as confirmed by radiological examination) 10. Patients with a diagnosis of active cancer 11. Patients with tattoos covering more than 30% of the area to be treated with LightForce® Therapy Lasers 12. Patients who are mentally or physically incapacitated 13. Patient participating in other clinical study or has completed a clinical study less than 30 days prior to enrollment 14. Patients with other clinically significant co-morbidities that make the patient unsuitable for study participation, at the discretion of the investigator